RxDoctor Payments Data

Pawandip Chima

Family · Sherman Oaks, CANPI 1760620231

Payments from drug & device makers

$435in general payments, 2019–2025

Across 24 payments — averaging $18.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Avanir Pharmaceuticals, Inc.$231
  • GSK$109
  • Johnson & Johnson$38
  • AbbVie$29
  • Sumitomo Pharma America, Inc.$14
  • Viatris Specialty LLC$14

What the payments were for

  • Food & beverage$435100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$435 in reported general payments places this provider in the 55th percentile of 10,634 family providers in California.

See all family providers in California

Medicare billing

Part B allowed, 2024
$280,196
Medicare patients
299
Services billed
3,334

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Duloxetine Hcl12$1,027
Ipratropium-AlbuterolIpratropium/Albuterol Sulfate15$371
Prednisone12$64

Paid to pharmacies, not to this prescriber.

Other family in Sherman Oaks

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →